~21 spots leftby Mar 2026

Continuous Peripheral Nerve Blocks for Phantom Limb Pain

Recruiting in Palo Alto (17 mi)
+7 other locations
Brian M. Ilfeld, MD - Anesthesiology ...
Overseen byBrian Ilfeld, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Waitlist Available
Sponsor: University of California, San Diego
No Placebo Group
Prior Safety Data

Trial Summary

What is the purpose of this trial?

When a limb is amputated, pain perceived in the part of the body that no longer exists often develops, called "phantom limb" pain. The exact reason that phantom limb pain occurs is unclear, but when a nerve is cut-as happens with an amputation-changes occur in the brain and spinal cord that are associated with persistent pain. The negative feedback-loop between the injured limb and the brain can be stopped by putting local anesthetic-called a "nerve block"-on the injured nerve, effectively keeping any "bad signals" from reaching the brain. A "continuous peripheral nerve block" (CPNB) is a technique providing pain relief that involves inserting a tiny tube-smaller than a piece of spaghetti-through the skin and next to the target nerve. Local anesthetic is then introduced through the tiny tube, which bathes the nerve in the numbing medicine. This provides a multiple-day block that provides opioid-free pain control with no systemic side effects, and may prevent the destructive feedback loop that results in phantom limb pain following an amputation. We propose a multicenter, randomized, triple-masked (investigators, subjects, statisticians), placebo-controlled, parallel arm, human-subjects clinical trial to determine if a prolonged, high-concentration (dense), perioperative CPNB improves post-amputation physical and emotional functioning while decreasing opioid consumption, primarily by preventing chronic phantom limb pain.

Research Team

Brian M. Ilfeld, MD - Anesthesiology ...

Brian Ilfeld, MD

Principal Investigator

University California San Diego

Eligibility Criteria

This trial is for individuals scheduled for unilateral lower limb amputation who are willing to have a nerve block infusion for 7 days, including after hospital discharge. They must not have liver or kidney issues, allergies to study meds, be pregnant or incarcerated, and must be able to communicate with researchers.

Inclusion Criteria

I am scheduled for a leg amputation below the hip that includes part of my foot.
I am willing to undergo a 7-day perineural infusion treatment.
I am scheduled for pain relief via nerve blocks around surgery time.
See 1 more

Exclusion Criteria

I have liver or kidney problems.
Allergy to any study medication
Pregnancy
See 6 more

Treatment Details

Interventions

  • Control continuous peripheral nerve blocks (Local Anesthetic)
  • Experimental continuous peripheral nerve blocks (Local Anesthetic)
Trial OverviewThe study tests if using a high-concentration continuous peripheral nerve block (CPNB) around the time of leg amputation can improve recovery by reducing phantom limb pain and opioid use. Participants will either receive the experimental CPNB or a control version in this randomized, triple-masked trial.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Bupivacaine 0.3% \[or ropivacaine 0.5%\] infusion for 7 days via femoral and sciatic perineural catheters
Group II: ControlExperimental Treatment1 Intervention
Bupivacaine 0.1% \[or ropivacaine 0.2%\] infusion for 1 day followed by normal saline for a total of 7 days via femoral and sciatic perineural catheters

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Naval Medical Center San DiegoSan Diego, CA
Mass. General HospitalBoston, MA
Brigham and Women's HospitalBoston, MA
Cleveland ClinicCleveland, OH
More Trial Locations
Loading ...

Who Is Running the Clinical Trial?

University of California, San Diego

Lead Sponsor

Trials
1215
Patients Recruited
1,593,000+

Wake Forest University Health Sciences

Collaborator

Trials
1432
Patients Recruited
2,506,000+

The Cleveland Clinic

Collaborator

Trials
1072
Patients Recruited
1,377,000+

Johns Hopkins University

Collaborator

Trials
2366
Patients Recruited
15,160,000+

Boston VA

Collaborator

Trials
1
Patients Recruited
200+

Mass. General Hospital

Collaborator

Trials
1
Patients Recruited
200+

Brigham and Women's Hospital

Collaborator

Trials
1694
Patients Recruited
14,790,000+

United States Department of Defense

Collaborator

Trials
940
Patients Recruited
339,000+

United States Naval Medical Center, San Diego

Collaborator

Trials
110
Patients Recruited
24,200+

Walter Reed National Military Medical Center

Collaborator

Trials
149
Patients Recruited
33,800+